| Pharma | Drug development | CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health | Dept. of the Army -- USAMRAA | 6/12/2020 |
| Pharma, Life Science Research | Drug development, mechanistic studies | CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health | Dept. of the Army -- USAMRAA | 6/12/2020 |
| Clinical | Therapeutic Drug Monitoring (clinical trials) | CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health | Dept. of the Army -- USAMRAA | 6/22/2020 |
| Clinical | Therapeutic Drug Monitoring (clinical trials) | CDMRP Peer Reviewed Medical Research Program Clinical Trial Award | Dept. of the Army -- USAMRAA | 8/13/2020 |
| Life Science Research | Metabolomics, Proteomics, Lipidomics | Fundamental Research to Counter Weapons of Mass Destruction | Defense Threat Reduction Agency | |
| Life Science Research | Metabolomics, Proteomics, Lipidomics | Biological Technologies | DARPA | 4/22/2021 |
| Food and Environmental | Environmental Monitoring | ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement | Centers for Disease Control - ATSDR | 5/8/2020 |
| All | Drug development, mechanistic studies | CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health | Dept. of the Army -- USAMRAA | 6/12/2020 |
| Life Science Research, Clinical | Research and Development | Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) | National Institutes of Health - NIAID | 4/29/2021 |
| Life Science Research, Clinical | Research and Development | Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) | National Institutes of Health - NIAID | 4/29/2021 |
| Life Science Research | Research and Development | NSF is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. | NSF - RAPID | |
| Life Science Research, Food & Environmental, Pharma | ALL | Fiscal Year (FY) 2021 DoD Research and Education Program for Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI) Equipment/Instrumentation. | Dept of the Army -- Materiel Command | 08/28/2020 |
| Forensic | Ports and Border security | Combatting COVID-19 Pandemic and Proliferation Threats | DOS-ISN | 05/29/2020 |
| Life Science Research, Food & Environmental, Pharma, Clinical | ALL | NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) | HHS-NIH11 | 09/30/2020 |
| Food & Environmental | Hazardous Waste Exposure | ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement | HHS-CDC-ATSDR | 06/30/2020 |
| Clinical/Life Science Research | Viral Research | Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence | National Institutes of Health | |
| Clinical/Life Science Research | Viral Research | Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) | National Institutes of Health | 07/22/2020 |
| Clinical/Life Science Research | Viral Research | Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) | National Institutes of Health | 07/22/2020 |
| Environmental/Industrial | Viral Research | ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement | Centers for Disease Control - ATSDR | 06/30/2020 |
| Life Science Research, Clinical Research | Mechanistic Studies | Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) | National Institutes of Health | 12/16/2020 |
| Life Science Research, Clinical Research, Clinical Dianostics | All | SARS-CoV-2 (COVID-19) Program Activities | Office of the Assistant Secretary for Health | |
| All | Academia | FY2021 VANNEVAR BUSH FACULTY FELLOWSHIP | Office of Naval Research | 01/15/2021 |
Contact Support